FDA Inspection 1121058 — North Carolina Center for Reproductive Medicine Inc (NCCRM)

North Carolina Center for Reproductive Medicine Inc (NCCRM) — FEI 1000501644

The FDA completed an inspection of North Carolina Center for Reproductive Medicine Inc (NCCRM) on March 16, 2020 in Cary, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 16, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Cary, NC (United States)